CPT code 92287 identifies a diagnostic ophthalmology procedure that evaluates the vasculature of the iris, most commonly to detect neovascularization associated with anterior segment neoplasms or other vascular abnormalities. Nationally, accurate coding for this specialized ocular vascular imaging is important for clinical tracking, care coordination, and appropriate claims processing within ophthalmology and outpatient diagnostic services.

Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise outline of the clinical context for 92287, common sites of service, and payer coverage considerations. The publication summarizes typical billing modifiers and payer interactions where available and highlights benchmarks and policy elements relevant to processing this ophthalmic diagnostic code.

The content provides clinical context, coding description, and operational points for revenue cycle and clinical teams to understand where 92287 fits within diagnostic eye care workflows. Data not available in the input is identified explicitly where applicable.